Skip Nav Destination

Issue Archive

Select Year

Issue

Volume 14, Issue 3

May-June 2017

In this Issue

Ask the Hematologist
Clinical Trials Corner
Diffusion
Features
Image Challenge
Op Ed
President’s Column
Program Genealogies

Ask the Hematologist

Ask the Hematologists: Von Willebrand Disease and Pregnancy

Caroline Berube, MD,Brian Dietrich, MD

View Articletitled, Ask the Hematologists: Von Willebrand Disease and Pregnancy

Clinical Trials Corner

Can Apixaban Succeed Where Others Have Failed?

Lori-Ann Linkins, MD, MSc(Clin Epi), FRCPC

View Articletitled, Can Apixaban Succeed Where Others Have Failed?

Diffusion

Identification of Recurrent Mutations in NFKBIE in Chemotherapy-Resistant Primary Mediastinal B-Cell Lymphoma

Caron A. Jacobson, MD

View Articletitled, Identification of Recurrent Mutations in NFKBIE in Chemotherapy-Resistant Primary Mediastinal B-Cell Lymphoma

Anticoagulation Failure in Venous Thromboembolism: Should We Test for JAK2 V617F or CALR Mutations?

Brandi N. Reeves, MD,Stephan Moll, MD

View Articletitled, Anticoagulation Failure in Venous Thromboembolism: Should We Test for JAK2 V617F or CALR Mutations?

Stopping Imatinib in CML: Safe in the Long Term for Deep Molecular Responders As the Immune System Steps Up

Andrew Roberts, MBBS, PhD, FRACP, FRCPA

View Articletitled, Stopping Imatinib in CML: Safe in the Long Term for Deep Molecular Responders As the Immune System Steps Up

SAMHD1 Is a Targetable Enzyme That Regulates Cytarabine Efficacy

Omar Abdel-Wahab, MD

View Articletitled, SAMHD1 Is a Targetable Enzyme That Regulates Cytarabine Efficacy

Taking a BiTE out of Relapsed or Refractory Acute Lymphocytic Leukaemia

Paul Moss, PhD

View Articletitled, Taking a BiTE out of Relapsed or Refractory Acute Lymphocytic Leukaemia

Precision Medicine at Work: Genetic Profiling to Guide Stem-Cell Transplantation in Myelodysplastic Syndromes

Sioban Keel, MD

View Articletitled, Precision Medicine at Work: Genetic Profiling to Guide Stem-Cell Transplantation in Myelodysplastic Syndromes

Utility of Flow Cytometry in Amyloid Light-Chain Amyloidosis

Parul Bhargava, MD,Tracy I. George, MD

View Articletitled, Utility of Flow Cytometry in Amyloid Light-Chain Amyloidosis

Seeing the Future

Jonathan Hoggatt, PhD

View Articletitled, Seeing the Future

High Prevalence of Ph-Like ALL Across the Age Spectrum

Elizabeth Raetz, MD

View Articletitled, High Prevalence of Ph-Like ALL Across the Age Spectrum

Another Therapeutic Agent in the Pipeline for Preventing Acute Vaso-Occlusive Events in Sickle Cell Disease

Michael DeBaun, MD, MPH

View Articletitled, Another Therapeutic Agent in the Pipeline for Preventing Acute Vaso-Occlusive Events in Sickle Cell Disease

Features

The Case for Abandoning Induction Chemotherapy

Daniel A. Pollyea, MD, MS

View Articletitled, The Case for Abandoning Induction Chemotherapy

A Joe Mikhael Icebreaker Fulfilled

Jason Gotlib, MD, MS

View Articletitled, A Joe Mikhael Icebreaker Fulfilled

Image Challenge

Hyperleukocytosis and Abnormal Complete Blood Count

View Articletitled, Hyperleukocytosis and Abnormal Complete Blood Count

Op Ed

Update From the Standing Committee on Promoting Diversity

Belinda Avalos, MD

View Articletitled, Update From the Standing Committee on Promoting Diversity

President’s Column

Standing Up for Patients

Kenneth C. Anderson, MD

View Articletitled, Standing Up for Patients

Program Genealogies

Program Genealogies: A History of Leukemia Research at MD Anderson Cancer Center (1965-Present)

Michael Keating, MD,Emil J Freireich, MD,Hagop M. Kantarjian, MD

View Articletitled, Program Genealogies: A History of Leukemia Research at MD Anderson Cancer Center (1965-Present)

Cover Image

Cover Image

All Issues

Advertisement intended for health care professionals

Email alerts

Latest Issue Alert

Continuous Publishing Alert

New Journal Content Alert

Latest
Most Read

Targeting the Natural History of Clonal Hematopoiesis

Ph- MPN in Adolescent and Young Adult Patients

An Australian Perspective on Bone Marrow Examination as a Standard Requirement for Hematology Trainees

ASH Committee Supports Care for Sickle Cell Disease on Capitol Hill

Colleagues Reflect on Legacy of Groundbreaking Hematologist Connie J. Eaves

Advertisement intended for health care professionals

Table of Contents

Ask the Hematologist

Ask the Hematologists: Von Willebrand Disease and Pregnancy

Clinical Trials Corner

Can Apixaban Succeed Where Others Have Failed?

Diffusion

Identification of Recurrent Mutations in NFKBIE in Chemotherapy-Resistant Primary Mediastinal B-Cell Lymphoma

Anticoagulation Failure in Venous Thromboembolism: Should We Test for JAK2 V617F or CALR Mutations?

Stopping Imatinib in CML: Safe in the Long Term for Deep Molecular Responders As the Immune System Steps Up

SAMHD1 Is a Targetable Enzyme That Regulates Cytarabine Efficacy

Taking a BiTE out of Relapsed or Refractory Acute Lymphocytic Leukaemia

Precision Medicine at Work: Genetic Profiling to Guide Stem-Cell Transplantation in Myelodysplastic Syndromes

Utility of Flow Cytometry in Amyloid Light-Chain Amyloidosis

Seeing the Future

High Prevalence of Ph-Like ALL Across the Age Spectrum

Another Therapeutic Agent in the Pipeline for Preventing Acute Vaso-Occlusive Events in Sickle Cell Disease

Features

The Case for Abandoning Induction Chemotherapy

A Joe Mikhael Icebreaker Fulfilled

Image Challenge

Hyperleukocytosis and Abnormal Complete Blood Count

Op Ed

Update From the Standing Committee on Promoting Diversity

President’s Column

Standing Up for Patients

Program Genealogies

Program Genealogies: A History of Leukemia Research at MD Anderson Cancer Center (1965-Present)

Email alerts

ASH Publications

American Society of Hematology

Issue Archive

Table of Contents

Ask the Hematologist

Clinical Trials Corner

Diffusion

Features

Image Challenge

Op Ed

President’s Column

Program Genealogies

Cover Image

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only